UBS AM
NXGN

UBS AM’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

UBS AM’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-59,684
Closed -$1.42M – 2631
2023
Q3 		$1.42M Buy
59,684
+2,791
+5% +$52.5K ﹤0.01% 1782
2023
Q2 		$991K Hold
56,893
– – ﹤0.01% 2014
2023
Q1 		$991K Sell
56,893
-13,317
-19% -$239K ﹤0.01% 2014
2022
Q4 		$1.32M Buy
70,210
+635
+0.9% +$12.2K ﹤0.01% 1720
2022
Q3 		$1.23M Buy
69,575
+8,679
+14% +$151K ﹤0.01% 1846
2022
Q2 		$1.06M Sell
60,896
-3,114
-5% -$59.4K ﹤0.01% 1925
2022
Q1 		$1.34M Sell
64,010
-2,128
-3% -$40.8K ﹤0.01% 1990
2021
Q4 		$1.18M Buy
66,138
+2,906
+5% +$46.7K ﹤0.01% 2130
2021
Q3 		$892K Buy
63,232
+15,136
+31% +$235K ﹤0.01% 2228
2021
Q2 		$798K Sell
48,096
-2,281
-5% -$40.9K ﹤0.01% 2329
2021
Q1 		$912K Buy
50,377
+1,900
+4% +$37.5K ﹤0.01% 2136
2020
Q4 		$884K Buy
48,477
+8,400
+21% +$133K ﹤0.01% 2051
2020
Q3 		$511K Hold
40,077
– – ﹤0.01% 2132
2020
Q2 		$440K Buy
40,077
+7,016
+21% +$72.7K ﹤0.01% 2170
2020
Q1 		$345K Sell
33,061
-7,765
-19% -$100K ﹤0.01% 2116
2019
Q4 		$656K Buy
40,826
+8,636
+27% +$143K ﹤0.01% 2117
2019
Q3 		$504K Buy
32,190
+14,592
+83% +$243K ﹤0.01% 2297
2019
Q2 		$350K Hold
17,598
– – ﹤0.01% 2353
2019
Q1 		$296K Buy
17,598
+1,500
+9% +$26K ﹤0.01% 2322
2018
Q4 		$244K Buy
+16,098
New +$276K ﹤0.01% 2303
2018
Q3 		– Sell
-16,098
Closed -$314K – 2832
2018
Q2 		$314K Sell
16,098
-13,519
-46% -$214K ﹤0.01% 2278
2018
Q1 		$404K Buy
29,617
+13,519
+84% +$178K ﹤0.01% 2107
2017
Q4 		$219K Hold
16,098
– – ﹤0.01% 2266
2017
Q3 		$253K Hold
16,098
– – ﹤0.01% 2149
2017
Q2 		$277K Hold
16,098
– – ﹤0.01% 2071
2017
Q1 		$245K Buy
+16,098
New +$237K ﹤0.01% 2088
2016
Q4 		– Sell
-22,198
Closed -$251K – 2702
2016
Q3 		$251K Hold
22,198
– – ﹤0.01% 2358
2016
Q2 		$264K Hold
22,198
– – ﹤0.01% 2287
2016
Q1 		$338K Sell
22,198
-2,200
-9% -$33.4K ﹤0.01% 2141
2015
Q4 		$393K Buy
24,398
+3,800
+18% +$55.5K ﹤0.01% 2188
2015
Q3 		$257K Hold
20,598
– – ﹤0.01% 2374
2015
Q2 		$341K Buy
20,598
+2,700
+15% +$43.5K ﹤0.01% 2286
2015
Q1 		$286K Buy
17,898
+1,000
+6% +$16.5K ﹤0.01% 2289
2014
Q4 		$263K Hold
16,898
– – ﹤0.01% 2314
2014
Q3 		$233K Hold
16,898
– – ﹤0.01% 2293
2014
Q2 		$271K Buy
16,898
+900
+6% +$14.2K ﹤0.01% 2242
2014
Q1 		$270K Buy
15,998
+1,800
+13% +$32.6K ﹤0.01% 2248
2013
Q4 		$299K Sell
14,198
-1,300
-8% -$29.3K ﹤0.01% 2140
2013
Q3 		$337K Hold
15,498
– – ﹤0.01% 2010
2013
Q2 		$290K Buy
+15,498
New +$283K ﹤0.01% 2008

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS AM's NXGN Position: Q4 2023 in Review

UBS AM sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 59,684 shares — an estimated $1.42M sold.

UBS AM first reported a position in NXGN in Q2 2013 and held it in 40 quarters. The position peaked at $1.42M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • UBS AM reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • UBS AM sold 59,684 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $1.42M.
  • UBS AM first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
  • UBS AM's NextGen Healthcare, Inc. Common Stock position peaked at $1.42M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.